Mymetics Corp (MYMX)

[Work Harder]

Stallergenes will finance all of DBV’s research on these aeroallergens and will have
development and commercialization rights

In the coming months, the parties will enter into license agreements for each
aeroallergen, defining the opt-in terms for development and commercialization.

https://www.dbv-technologies.com/wp-content/uploads/2017/09/1352pr_dbv_stallergen-enter-into-partne.pdf

https://adisinsight.springer.com/drugs/800038127